Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes

Abstract Purpose Evaluation of dose degradation by anatomic changes for head‐and‐neck cancer (HNC) intensity‐modulated proton therapy (IMPT) relative to intensity‐modulated photon therapy (IMRT) and identification of potential indicators for IMPT treatment plan adaptation. Methods For 31 advanced HNC datasets, IMPT and IMRT plans were recalculated on a computed tomography scan (CT) taken after about 4 weeks of therapy. Dose parameter changes were determined for the organs at risk (OARs) spinal cord, brain stem, parotid glands, brachial plexus, and mandible, for the clinical target volume (CTV) and the healthy tissue outside planning target volume (PTV). Correlation of dose degradation with target volume changes and quality of rigid CT matching was investigated. Results Recalculated IMPT dose distributions showed stronger degradation than the IMRT doses. OAR analysis revealed significant changes in parotid median dose (IMPT) and near maximum dose (D 1ml) of spinal cord (IMPT, IMRT) and mandible (IMPT). OAR dose parameters remained lower in IMPT cases. CTV coverage (V 95%) and overdose (V 107%) deteriorated for IMPT plans to (93.4 ± 5.4)% and (10.6 ± 12.5)%, while those for IMRT plans remained acceptable. Recalculated plans showed similarly decreased PTV conformity, but considerable hotspots, also outside the PTV, emerged in IMPT cases. Lower CT matching quality was significantly correlated with loss of PTV conformity (IMPT, IMRT), CTV homogeneity and coverage (IMPT). Target shrinkage correlated with increased dose in brachial plexus (IMRT, IMPT), hotspot generation outside the PTV (IMPT) and lower PTV conformity (IMRT). Conclusions The study underlines the necessity of precise positioning and monitoring of anatomy changes, especially in IMPT which might require adaptation more often. Since OAR doses remained typically below constraints, IMPT plan adaptation will be indicated by target dose degradations.

[1]  Kristin Stützer,et al.  Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis. , 2017, International journal of radiation oncology, biology, physics.

[2]  A. Lomax,et al.  Effect of Anatomic Changes on Pencil Beam Scanned Proton Dose Distributions for Cranial and Extracranial Tumors. , 2017, International journal of radiation oncology, biology, physics.

[3]  Brian Winey,et al.  Water equivalent path length calculations using scatter-corrected head and neck CBCT images to evaluate patients for adaptive proton therapy , 2017, Physics in medicine and biology.

[4]  A. Lomax,et al.  Evaluation of Robustness to Setup and Range Uncertainties for Head and Neck Patients Treated With Pencil Beam Scanning Proton Therapy. , 2016, International journal of radiation oncology, biology, physics.

[5]  Liyong Lin,et al.  First Clinical Investigation of Cone Beam Computed Tomography and Deformable Registration for Adaptive Proton Therapy for Lung Cancer. , 2016, International journal of radiation oncology, biology, physics.

[6]  Danny Lathouwers,et al.  Robustness Recipes for Minimax Robust Optimization in Intensity Modulated Proton Therapy for Oropharyngeal Cancer Patients. , 2016, International journal of radiation oncology, biology, physics.

[7]  Mechthild Krause,et al.  Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.

[8]  David Craft,et al.  Multi-criteria optimization achieves superior normal tissue sparing in a planning study of intensity-modulated radiation therapy for RTOG 1308-eligible non-small cell lung cancer patients. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  A Bel,et al.  Beam configuration selection for robust intensity-modulated proton therapy in cervical cancer using Pareto front comparison , 2016, Physics in medicine and biology.

[10]  A. Lühr,et al.  Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy , 2015, Front. Oncol..

[11]  T. Solberg,et al.  The Impact of Anatomic Change on Pencil Beam Scanning in the Treatment of Oropharynx Cancer , 2015 .

[12]  Huixian Huang,et al.  Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy , 2015, Radiation oncology.

[13]  A. Lühr,et al.  NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy , 2015, Acta oncologica.

[14]  M. Stock,et al.  ART for head and neck patients: On the difference between VMAT and IMPT , 2015, Acta oncologica.

[15]  Steffen Löck,et al.  Identification of Patient Benefit From Proton Therapy for Advanced Head and Neck Cancer Patients Based on Individual and Subgroup Normal Tissue Complication Probability Analysis. , 2015, International journal of radiation oncology, biology, physics.

[16]  S. Nill,et al.  Impact of interfractional changes in head and neck cancer patients on the delivered dose in intensity modulated radiotherapy with protons and photons. , 2015, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

[17]  A J Lomax,et al.  Defining robustness protocols: a method to include and evaluate robustness in clinical plans , 2015, Physics in medicine and biology.

[18]  P. Haigron,et al.  Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomia , 2015, Radiation oncology.

[19]  James A Purdy,et al.  Clinical outcomes among patients with head and neck cancer treated by intensity‐modulated radiotherapy with and without adaptive replanning , 2014, Head & neck.

[20]  R. Mohan,et al.  Multifield optimization intensity modulated proton therapy for head and neck tumors: a translation to practice. , 2014, International journal of radiation oncology, biology, physics.

[21]  Hanne M Kooy,et al.  Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors. , 2013, International journal of radiation oncology, biology, physics.

[22]  Wei Liu,et al.  Preliminary evaluation of multifield and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer. , 2013, Medical physics.

[23]  D. Shimm.  Clinical Target Volumes in Conformal and Intensity Modulated Radiation Therapy: A Clinical Guide to Cancer Treatment , 2013 .

[24]  Steven J Frank,et al.  A novel dose-based positioning method for CT image-guided proton therapy. , 2013, Medical physics.

[25]  Lei Dong,et al.  Physics controversies in proton therapy. , 2013, Seminars in radiation oncology.

[26]  J. Giralt,et al.  Dose variations in tumor volumes and organs at risk during IMRT for head‐and‐neck cancer , 2012, Journal of applied clinical medical physics.

[27]  Michael Baumann,et al.  Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  T. Kataria,et al.  Homogeneity Index: An objective tool for assessment of conformal radiation treatments , 2012, Journal of medical physics.

[29]  T. Schuster,et al.  Adaptive radiotherapy for soft tissue changes during helical tomotherapy for head and neck cancer , 2012, Strahlentherapie und Onkologie.

[30]  Johannes A Langendijk,et al.  Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer. , 2011, International journal of radiation oncology, biology, physics.

[31]  Johannes A Langendijk,et al.  The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature. , 2011, The oncologist.

[32]  M. Truong,et al.  Brachial plexus contouring with CT and MR imaging in radiation therapy planning for head and neck cancer. , 2010, Radiographics : a review publication of the Radiological Society of North America, Inc.

[33]  Xavier Geets,et al.  Assessment by a deformable registration method of the volumetric and positional changes of target volumes and organs at risk in pharyngo-laryngeal tumors treated with concomitant chemo-radiation. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Kevin J Harrington,et al.  Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study. , 2010, International journal of radiation oncology, biology, physics.

[35]  Xavier Geets,et al.  Adaptive radiotherapy of head and neck cancer. , 2010, Seminars in radiation oncology.

[36]  Johannes A Langendijk,et al.  Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[37]  Srinivasan Vijayakumar,et al.  Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. , 2008, International journal of radiation oncology, biology, physics.

[38]  Richard A Popple,et al.  Effect of beam number on organ-at-risk sparing in dynamic multileaf collimator delivery of intensity modulated radiation therapy. , 2007, Medical physics.

[39]  Nancy Lee,et al.  Intensity‐modulated radiation therapy in head and neck cancers: An update , 2007, Head & neck.

[40]  Radhe Mohan,et al.  Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system. , 2004, International journal of radiation oncology, biology, physics.

[41]  A Fogliata,et al.  A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[42]  M. Moerland,et al.  A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. , 1997, International journal of radiation oncology, biology, physics.

[43]  Lei Dong,et al.  Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  Yasumasa Nishimura,et al.  Volume and dosimetric changes and initial clinical experience of a two-step adaptive intensity modulated radiation therapy (IMRT) scheme for head and neck cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[45]  Shixiu Wu,et al.  The role of replanning in fractionated intensity modulated radiotherapy for nasopharyngeal carcinoma. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  G. Cosnard,et al.  Selection and Delineation of Lymph Node Target Volumes in Head and Neck Conformal and Intensity-Modulated Radiation Therapy , 2004 .